Improvement of Mouth Functional Disability in Systemic Sclerosis Patients over One Year in a Trial of Fat Transplantation versus Adipose-Derived Stromal Cells

Table 1

Patients’ characteristics: A: patients treated with ADSCs injection and L: patients treated with fat transplantation.

Patients	Age	Disease status	Disease duration	Localized scleroderma
1 A	23	1-year disease stabilization	3 years	Face and hands
2 A	25	9-year disease stabilization	5 years	Face
3 A	35	6-year disease stabilization	10 years	Face
4 A	38	6-year disease stabilization	10 years	Face
5 A	39	15-year disease stabilization	13 years	Face and hands
1 L	24	5-year disease stabilization	3 years	Face and hands
2 L	25	8-year disease stabilization	3 years	Face and hands
3 L	36	16-year disease stabilization	12 years	Face
4 L	39	8-year disease stabilization	15 years	Face
5 L	48	6-year disease stabilization	18 years	Face and hands